LEXINGTON, Ky. ­­— Richmond, Virginia-based biotech company Aditxt Inc. has partnered with Lexington-based clinical diagnostic lab SphereDX to offer an advanced COVID-19 monitoring tool called AditxtScore for COVID-19. The AditxtScore for COVID-19 is a blood test that acts as a comprehensive immune response monitoring tool that tracks multiple combinations of antibodies and neutralizing antibody responses against several different antigens, according […]

Regulus Therapeutics just finished dosing patients in toxicity studies for its second-generation autosomal dominant polycystic kidney disease (ADPKD) candidate RGLS8429. Based on FDA discussions and data from a Phase Ib trial on original ADPKD candidate RGLS4326, Regulus is shifting away from the first-generation candidate and prioritizing the newer candidate, according to a statement.

BioNova Pharmaceuticals has a couple molecules in early development for blood cancers, but, in an effort to get to the clinic faster, the biotech is doling out $200 million to Sutro Biopharma for some more advanced treatments. The Shanghai biotech will pay an initial $4 million to license the San Francisco-based company’s CD74-targeting antibody-drug conjugate for development […]